S1605 HORIZON (OP-106): UPDATED EFFICACY AND SAFETY OF MELFLUFEN IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) REFRACTORY TO DARATUMUMAB (DARA) AND/OR POMALIDOMIDE (POM)
Richardson, P.G., Oriol, A., Larocca, A., Otero, P. R., Norkin, M., Bladé, J., Cavo, M., Hassoun, H., Leleu, X., Alegre, A., Maisel, C., Paner, A., Mazumder, A., Zonder, J. A., Puig, N., Harran, J.,Volume:
3
Journal:
HemaSphere
DOI:
10.1097/01.hs9.0000564668.83577.40
Date:
June, 2019
File:
PDF, 440 KB
2019
File converter
More search results
More benefits 
